Skip to content

Merck & Co. MRK EV / sales

EV / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
3.3×-0.1×
Pfizer logo
PfizerPFE
3.5×+0.3×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.5×+0.6×
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
10,042.9×+9,939×
Amgen logo
AmgenAMGN
6.6×+0.1×

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$285.12B+31.2%
Enterprise value$328.82B+34.2%
P/E31.9×+19.4×
P/S4.3×+0.9×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Calculated from Merck & Co.’s reported figures.

Based on the most recent quarter.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s EV / sales?
Merck & Co. (MRK) reported EV / sales of 5.2× in Q1 2026.
How has Merck & Co.'s EV / sales changed year-over-year?
Merck & Co.'s EV / sales increased by 30.4% year-over-year, from 4× to 5.2×.
What is the long-term trend for Merck & Co.'s EV / sales?
Over 4 years (2021 to 2025), Merck & Co.'s EV / sales has grown at a -5.0% compound annual growth rate (CAGR), from 19.5× to 15.8×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.